TrialCA: a cancer journal for clinicians

Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trial.

Ling-Long Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.